The session will focus on what lies ahead for companies making the transformation from private entity to public enterprise, including what to expect in the evolving capital marketplace, the political and regulatory impacts on transition and emerging trends in public readiness. The afternoon will feature local executive panelists on the forefront of the changing capital market.
The Politics of Capital: A Discussion on Current Political Impacts on Transitioning from Private to Public
- John Cox, Chief Executive Officer, Bioverativ
- Jonas Svedlund, General Counsel, Head of Legal & Transactions, GE Ventures
- Robert Coughlin, President & Chief Executive Officer, Massachusetts Biotechnology Council
- Moderated by Arthur McGivern, Partner, Goodwin
How will the new administration’s influence on tax policy, along with general policy issues (public policy, FDA approval, drug pricing, healthcare reform, etc.) impact the capital market landscape as well as your company's path towards a liquidation event?